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The renin-angiotensin system (RAS) plays an important role in regulation of the systemic blood pressure, body fluid, and electrolyte balance. Angiotensin II (AT-II), an octapeptide produced by proteolytic cleavage of its precursor angiotensin by the angiotensin-converting enzyme (ACE), is a physiologically active product of the RAS (Matsusaka and Ichikawa, 1997) . It stimulates the proliferation of mesangial cells, cardiac fibroblasts, and hepatic stellate cells (HSCs) and their increased synthesis of extracellular matrix proteins through induction of transforming growth factor (TGF)-ß 1 expression both in vivo and in vitro (Matsusaka and Ichikawa, 1997; Bataller et al., 2000) .
Two subtypes of AT-II receptors, namely type 1 (AT1 receptor) and type 2 (AT2 receptor), have been identified (Matsusaka and Ichikawa, 1997; Matsubara, et al., 1998) .
AT1 receptor, which mediates most of the biological results of AT-II action, including vasoconstriction, cell proliferation, and production of extracellular matrix proteins, is found in the kidney, liver, adrenal cortex, and blood vessels. It is well documented that AT-II induces cell hypertrophy and ion transport in the kidney, heart, and liver, primarily through AT1 receptor (Matsusaka and Ichikawa, 1997; Bataller et al., 2000) . In contrast, AT2 receptor is expressed at high levels in the various organs of developing fetus, while, in the adults, it is mainly present in the brain, adrenal medulla, uterus, and heart. This form, which is This article has not been copyedited and formatted. The final version may differ from this version.
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Downloaded from JPET #53322 6 increased during inflammation and ischemia, suppresses synthesis of DNA, protein, and extracellular matrix proteins, as well as cell proliferation (Matsusaka and Ichikawa, 1997; Matsubara, 1998) . ACE inhibitors suppress functions of both AT1 and AT2 receptors by depleting AT-II. On the other hand, AT-II may stimulate AT2 receptor in the presence of an AT1 receptor
antagonist.
It has been demonstrated that mRNAs for RAS components, including angiotensinogen, renin, and ACE are active intrinsically in the pancreas and their levels are enhanced during acute pancreatitis and chronic pancreatic hypoxia in experimental animals Chan et al., 2000) .
Isolated pancreatic stellate cells (PSCs) have similar properties to their counterparts in the liver, HSCs, with regard to shape, presence of vitamin A, positive staining for desmin and glial fibrillary acidic protein, and expression for α-smooth muscle actin (SMA) in the active phase (Apte et al., 1998; Schneider et al., 2001) . It was reported that TGF-ß1 induces proliferation of PSCs and their increased production of extracellular matrix proteins and PSCs are involved in the pathogenesis of pancreatic fibrosis in both experimental animals and humans . AT-II induces contraction and proliferation of HSCs in vitro and AT1 receptor antagonists reduce hepatic fibrosis by suppressing activation of HSCs in experimental animals (Bataller et al., 2000; Yoshiji et al., 2001 ).
This article has not been copyedited and formatted. The final version may differ from this version. (Kuno et al., 2003) .
ACE inhibitors increase levels of the vasodilatory prostaglandins and nitric oxide (Johnson et al., 1995; Schaefer et al., 1996) , which may be involved in the protective mechanisms. Therefore, it is not clear whether AT-II and its interaction with AT1 receptor is important for the pathogenes is.
Further, ACE inhibitors occasionally cause acute pancreatitis in human (Muchnick, 1999) . We assumed that the effect of an AT1 receptor antagonist should be assess ed to clarify the involvement of AT-II and AT1
receptor interaction and an AT1 receptor antagonist might be more suitable for treating chronic pancreatitis. However, there is no information available regarding its effect on pancreatic inflammation and fibrosis as well as pancreatic RAS. Therefore, in the present study, we assessed the effects of candes artan, an AT1 receptor antagonis t, on 1) pancreatic inflammation and fibrosis, 2) the gene expression of TGF-ß 1 and local RAS components, including angiotensinogen, AT1 receptor, and AT2 receptor, and 3) ratio of 
Groups of Animals and Treatment
Ten-week-old WBN/Kob rats were randomly divided into untreated (n=9), low (n=5), medium (n=5), and high (n=10) dose candesartan groups.
Candesartan (100 mg) was dissolved in 1:1 mix of ethanol and polyethylene glycol (1.2 mL), warmed to 60 centigrade, and then 1 N sodium bicarbonate solution (3.3 mL) was added before being dissolved in drinking water. The high dose concentration of candesartan in drinking water, 125 mg/L, was selected on the basis of a previous report (Kim et al., 1995) and intake was estimated to be 10 mg/kg/day (Kuno et al., 2003) . Lower c oncentrations of candesartan (42 or 10.5 mg/L) were also tested to assess dose-dependence.
Untreated group was given water containing equal volume of ethanol, (Hashimoto et al., 2000; Yamada et al., 2001; Kuno et al., 2003) and is considered to be suitable to determine prophylactic effects of drugs on chronic inflammation and fibrosis since pancreatic lesions does not exist at 10 weeks of age and chronic inflammation and fibrosis almost completely involve the pancreas at 20 weeks in the present model (Mori et al., 1988) .
Twenty-week-old male Wistar rats (n=5) were used for determination of body weight, pancreas weight, pancreatic myeloperoxidase (MPO) activity, pancreatic hydroxyproline content, and mRNAs for TGF-ß 1, angiotensinogen, AT1 receptor, and AT2 receptor in the pancreas.
Tissue Sampling
Twenty-week-old WBN/Kob rats treated for 10 weeks were killed with an overdose of pentobarbital sodium (Abbott Laboratories, North
Chicago, IL, USA) after taking blood from the abdominal aorta and 20-week-old Wistar rats were also killed to obtain pancreas. Samples were also fixed in 10% buffered formalin for histological assessment and immunohistochemistry (WBN/Kob rats: untreated, n=6; low dose, n=5; medium dose, n=5; and high dose, n=5).
Histological Analysis
Pancreas tissue was fixed with 10% buffered formalin, processed for paraffin embedding sectioned, and stained with hematoxylin-e osin and Azan.
Microscopic examination was carried out by a pathologist who was unaware of the groups of rats. The status of inflammation was evaluated in terms of the grades of inflammatory cell infiltration, interstitial edema, fibrosis, acinar cell necrosis, and hemorrhage on a scale of negligible to maximal (0-3), as reported previously (Hashimoto et al., 2000) . The scores were compared among the untreated and low, medium, and high dose candesartan Osaka, Japan) as the ratio of anilin-blue positive fibrous tissue to total area in Azan-stained pancreas s ections, excluding lymph nodes and major vessels, if present.
Immunohistochemistry for α-Smooth Muscle Actin
Pancreas sections fixed in 10% buffered formalin were treated with 0.3% hydrogen peroxide in methanol to block endogenous peroxidase activity. After washing with phosphate buffered saline, they were treated for 1 hour at room temperature with 5% fetal bovine serum to block nonspecific reactions. They were then incubated overnight at room temperature with mouse anti-human α-SMA mAb (1:750 dilution; Dako, Carpiteria, CA) which can detect rat α-SMA. After washing, the sections were incubated for 1 hour at room temperature with biotinylated rabbit anti-mouse immunoglobulin G antibody (1:500 dilution; Dako) and then for JPET #53322 12
Measurement of Pancreatic Myeloperoxidase Activity
Pancreatic MPO activity, an indirect quantitative index of granulocyte infiltration, was determined using the method of Grisham et al. (1990) with a minor modification. Briefly, pancreatic tissue was homogenized in 20 mM phosphate buffer (pH 7.4) and the homogenate was 
Measurement of Pancreatic Hydroxyproline Content
Pancreatic hydroxyproline content, an indicator of collagen deposition, was determined by a modification of the method of Blumenkrantz and Asboe-Hansen (1973) . Briefly, approximately 100 mg specimens were homogenized in water and hydrolyzed at 110 centigrade for JPET #53322 13 consisting of toluene (5 parts), 2-methyl-1-propanol ( 5 parts), and 1-propanol (2 parts), shaken for 30 min and centrifuged. The organic phase (0.6 mL) was mixed with Ehrlich's reagent (0.15 mL) and left for 15 min.
The absorbance was measured at 565 nm and hydroxyproline levels were calculated using a standard curve made with 4-hydroxy-1 -proline and expressed as micrograms per gram tissue.
Measurement of Serum Candesartan Levels
Serum candesartan levels were determined in the low (n=5), medium (n=5), and high (n=5) dose groups. Briefly, after serum was mixed with 0.2 M HCl and diethyl ether, the organic layer was obtained by centrifugation and freezing of the aqueous layer using a dry-ice acetone bath, then evaporated under nitrogen gas at 40 centigrade, and the residue was mixed with 0.02M KH2 PO4 /CH3 CN (8:2; vol/vol), vortexed, sonicated, and centrifuged, and the concentration of candesartan in the supernatant was determined using hyper liquid chromatography.
Reverse Transcription-Polymerase Chain Reaction
Total RNA was extracted from frozen pancreatic tissues with Trizol reagent (Invitrogen Co., Carlsbad, CA. USA) and 2 mg was reverse transcribed into cDNA using an Oligo (dT) 12-18 Primer (Invitrogen Co.), The PCR primers, designed in line with previous reports (Bouhnik et al., 1981; Qian et al., 1990; Iwai et al., 1991; Iwai and Inagami, 1992; Koike et al., 1995) 
Statis ti cs
Data are expressed as arithmetic means ± standard deviation.
Statistical differences between two groups or among groups were identified using the Student t test or one-wa y analysis of variance, followed by multiple comparisons using the least significant difference method, 
Results

Doses and Serum Levels of Candesartan, Body Weight, and Pancreas
Wei g ht
The average doses of candesartan calculated from water consumption and body weights of low, medium, and high dose groups were 0.80 ± 0.08, 4.34 ± 0.32, and 13.92 ± 0.98 mg/kg/day, respectively, during the experimental period. Serum candesartan levels were 55.0 ± 24.6, 442.0 ± 112.6, and 914.6 ± 382.0 ng/mL, respectively, in the low, medium, and high groups at the end of the experiment (Table 1 ). The pancreas weights were significantly lower in the untreated group than those in the age matched male Wistar rats ( Table 1 ). The body weights were significantly lower in the medium and high dose groups than the untreated and low dose groups, while the pancreas weights increased significantly in all treatment groups compared with the untreated group (Table 1) .
Macroscopic Findings
The pancreases in the untreated and low dose groups were severely atrophic and had widely s pread brown and red foci. In contrast, the pancreases in the high dose group had an almost intact appearance, and the medium dose group had only a few brown and red foci.
Histopathological Analysis
In the untreated rats, severe inflammation was focally observed This article has not been copyedited and formatted. The final version may differ from this version. JPET #53322 17 around pancreatic ducts (Fig. 1A) . It was characterized by neutrophil and lymphocyte infiltration, interstitial edema, hemorrhage and occasional acinar cell necrosis ( Fig. 1A ; le ft -half side). Fibrosis was noted as replacement of vanished acini and was also seen between acini and fine to thick collagen fibers were stained in blue in the untreated group ( Fig. 1B; left -half side). The administration of candesartan dramatically reduced the inflammatory changes in a dose-dependent manner. Table 2 summarizes the average scores for each factor and the quantitative data for fibrous tissue.
The inflammator y cell infiltration and interstitial edema were significantly reduced in the medium and high dose groups (Table 2) . Focal inflammatory changes were only slight around the ducts and fine collagen fiber is present in the high dose group ( Fig. 1C and 1D ; arrows).
Immunohistochemistry for α-Smooth Muscle Actin
α-SMA positive cells with the morphology of activated PSCs were localized in the peri-acinar fibrotic areas and vascular walls in the untreated group ( Fig. 2A ; right-half side). In contrast, α-SMA positive cells were observed only in the vascular walls in the high dose candesartan group (Fig.   2B ), demonstrating significant decrease (Table 2) .
Pancreatic Myeloperoxidase Activity
Pancreatic MPO activity, an index of granulocyte infiltration, was significantly increased in untreated group compared with the Wistar rats This article has not been copyedited and formatted. The final version may differ from this version. 
Pancreatic Hydroxyproline Content
Pancreatic hydroxyproline content, an indicator of collagen deposition, was significantly increased in untreated group compared with the Wistar rats (537.6 ± 292.9 vs. 139.6 ± 38.4 µ g/g, p<0.005). The high dose of candesartan significantly suppressed the increase in pancreatic hydroxyproline content compared with the untreated, low, and medium dose groups (146.6 ± 56.4 vs 537.6 ± 292.9, 390.9 ± 198.5 and 385.9 ± 90.7 µ g/g, p<0.01, res pectively).
Expression of TGF-ß1, Angiotensinogen, AT1 receptor and AT2 receptor mRNA
RT-PCR revealed TGF-ß 1 mRNA to be overexpressed in the pancreas in the untreated group, while it was only detected at low levels in male
Wistar rats (Fig. 3) . The high dose of candesartan suppressed the overexpression of TGF-ß1 mRNA in WBN/Kob rats (Fig. 3) . The expressions of angiotensinogen and AT2 receptor were enhanced in the high dose group compared with untreated group and Wistar rats, whereas that of AT1 receptor was only slightly increased (Fig. 3) .
This article has not been copyedited and formatted. The final version may differ from this version. Male WBN/Kob rats spontaneously develop chronic pancreatitis (Mori et al., 1988) . We previously demonstrated induction of acinar cell apoptosis, with infiltration of CD8 and CD4 T cells and tacrolimus, an immunosuppressant, attenuates this apoptosis and chronic inflammation in this model (Hashimoto et al., 2000; Yamada et al.,2001) . Clinical pancreatitis, suggesting that cell-mediated autoimmune mechanisms are at work (Anderson et al., 1988; Bedossa et al., 1990 , Jalleh et al., 1993 Yoshida et al., 1995) . Further, autoimmune chronic pancreatitis has been recognized as a new entity in humans defined in terms of lymphocyte infiltration, autoantibody production, and effectiveness of steroid administration (Okazaki et al., 2000) . We can speculate that the present model, at least in part, may re flect chronic pancreatitis in man and may thus be useful for exploring clinical therapeutic strategies.
AT-II, a potent constrictor of vascular smooth muscle cells, and its receptor interaction play important roles in endocrine regulation of pancreatic blood flow in rodents (Leung et al., 1997) and humans (Tahmasebi et al., 1999) . Many investigations have demonstrated that AT-I I and AT1 receptor interaction is also involved in the pathogenesis of fibrosis in the kidney, heart, and liver during chronic inflammation (Matsusaka and Ichikawa, 1997; Bataller et al., 2000; Yoshiji et al., 2001 ). Furthermore, it was documented that RAS mRNAs and proteins are present in the pancreas and enhanced in acute experimental pancreatitis and chronic pancreatic hypoxia Chan et al., 2000) . We recently demonstrated This article has not been copyedited and formatted. The final version may differ from this version. (Kuno et al., 2003) . However, ACE inhibitors activate the kallikrein-kinin system and preserve bradykinin (White, 1998) . The latter is a vasodilator and increases levels of the vasodilatory prostaglandins and nitric oxide (Johnson et al., 1995; Shaefer et al., 1996) . Thus, the protection mediated by an ACE inhibitor may not mean direct involvement of AT-II and AT1 receptor in the pathogenesis of pancreatic inflammation and fibrosis. We confirmed an importance of AT-I I and its interaction with an AT1 receptor in the present model. Our findings further suggested that the protective effect of AC E inhibitor observed in the present model may be mediated by inhibiting conversion of AT-I to AT-I I although involvement of vasodilatory factors may not completely be denied.
It was reported that ischemia may be involved in the pathogenesis of chronic pancreatitis in the WBN/Kob rats (M ori et al., 1988) . We (Tsukamoto et al., 2000) . Further, an AT1 receptor antagonist ameliorates increased expressions of Mac-1 and intercellular adhesion molecule-1 in stroke -prone spontaneously h ypertensive rats (Takemori et al., 2000) and reduces hepatic ischemia-reperfusion injury by decreasing production of cytokines, including TNF-α and IL-6 in rats (Araya et al., 2002) . Pancreatic inflammation and fibrosis is associated with up-regulation of tissue expressions of TNF-α and IL-6 in the present model (Xie et al. 2001) . Taken together, we assumed that candesartan may reduce inflammation by suppressing cytokines and adhesion molecules. However, additional studies are needed to clarify these points.
It has been demonstrated that AT2 receptor is up-regulated by insulin, insulin-like growth factor, or cytokines (Matsubara, 1998) . We presented 
